Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 10/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.40 |
| ▸ | ACACA | Q13085 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19995149 | 1.00 | ADORA2B (0.41) | ADORA2BADORA2AADORA1ADORA3ACACA | |
| SCHEMBL19995239 | 0.94 | ADORA2B (0.40) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19995238 | 0.94 | ADORA2B (0.40) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19995130 | 0.92 | ADORA2B (0.42) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19995131 | 0.92 | ADORA2B (0.42) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19994313 | 0.92 | ADORA2B (0.39) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19994308 | 0.91 | ADORA2B (0.41) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19995407 | 0.91 | ADORA2B (0.41) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19994307 | 0.91 | ADORA2B (0.41) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL19995406 | 0.91 | ADORA2B (0.41) | ADORA2BADORA2AADORA1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3515919-A1 | N3-CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF | Bayer Aktiengesellschaft (DE) | 2019-07-31 | — | — | EP | disclosed |
| WO-2018054846-A1 | N3-CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2018-03-29 | — | — | WO | disclosed |